COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #15 of 231
4/17 Post Exposure Prophylaxis study (treated after exposure to the virus)
Lee at al., Int. J. Antimicrob. Agents, 2020, Apr 17, doi:10.1016/j.ijantimicag.2020.105988 (Peer Reviewed)
Can Post-Exposure Prophylaxis for COVID-19 Be Considered as an Outbreak Response Strategy in Long-Term Care Hospitals?
Source   PDF   Share   Tweet
Post exposure prophylaxis of 211 high-risk people after major exposure event in a long term care hospital, showing no positive cases after 14 days.

Lee et al., 4/17/2020, peer-reviewed, 3 authors.
Details of all 231 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit